Shanghai Rightongene Biotechnology 대차 대조표 상태
재무 상태 기준 확인 4/6
Shanghai Rightongene Biotechnology has a total shareholder equity of CN¥948.1M and total debt of CN¥20.8M, which brings its debt-to-equity ratio to 2.2%. Its total assets and total liabilities are CN¥1.0B and CN¥66.9M respectively.
주요 정보
2.2%
부채 비율
CN¥20.77m
부채
| 이자 보상 비율 | n/a |
| 현금 | CN¥224.25m |
| 주식 | CN¥948.10m |
| 총 부채 | CN¥66.93m |
| 총 자산 | CN¥1.02b |
최근 재무 상태 업데이트
업데이트 없음
Recent updates
Shanghai Rightongene Biotechnology Co., Ltd.'s (SHSE:688217) Share Price Boosted 32% But Its Business Prospects Need A Lift Too
Oct 18
Shanghai Rightongene Biotechnology Co., Ltd. (SHSE:688217) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough
Jul 23Investors Can Find Comfort In Shanghai Rightongene Biotechnology's (SHSE:688217) Earnings Quality
Apr 23재무 상태 분석
단기부채: 688217's short term assets (CN¥484.9M) exceed its short term liabilities (CN¥39.1M).
장기 부채: 688217's short term assets (CN¥484.9M) exceed its long term liabilities (CN¥27.9M).
부채 대 자본 내역 및 분석
부채 수준: 688217 has more cash than its total debt.
부채 감소: 688217's debt to equity ratio has increased from 0.3% to 2.2% over the past 5 years.
부채 범위: 688217's debt is well covered by operating cash flow (232.5%).
이자 보장: Insufficient data to determine if 688217's interest payments on its debt are well covered by EBIT.